Comparison of the prophylactic use of ibandronate and its use in early-stage osteonecrosis in rats with steroid-induced osteonecrosis of the femoral head
Open Access
- 21 August 2023
- journal article
- research article
- Published by Joint Diseases and Related Surgery in Joint Diseases and Related Surgery
- Vol. 34 (3) , 640-650
Abstract
Joint Diseases and Related Surgery (JDRS), the official journal of the Turkish Joint Diseases Foundation, is an international, peer-reviewed, immediate open access journal. All published articles in JDRS has been free for everyone, without embargo, since 1990.Keywords
This publication has 34 references indexed in Scilit:
- Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: What we think we know and what we know that we don't knowBone, 2011
- Current and emerging therapies for the treatment of osteoporosisJournal of Experimental Pharmacology, 2010
- Bisphosphonate Therapeutics in Bone Disease: The Hard and Soft Data on Osteoclast InhibitionMolecular Interventions, 2010
- Higher doses of bisphosphonates further improve bone mass, architecture, and strength but not the tissue material properties in aged ratsBone, 2010
- Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged miceAging Cell, 2010
- Local bioavailability and distribution of systemically (parenterally) administered ibandronate in the infarcted femoral headBone, 2006
- Bisphosphonate (YM529) delays the repair of cortical bone defect after drill-hole injury by reducing terminal differentiation of osteoblasts in the mouse femurBone, 2005
- Efficacy of alendronate, a bisphosphonate, in the treatment of AVN of the hip. A prospective open-label studyRheumatology, 2005
- Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal WomenNew England Journal of Medicine, 2004
- Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitoninJournal of Clinical Investigation, 1999